-
1.
公开(公告)号:US20140315886A1
公开(公告)日:2014-10-23
申请号:US14129805
申请日:2012-06-28
申请人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahahi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimiza , Kevin J. Hodgetts , Jason S. Newcom
发明人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahahi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimiza , Kevin J. Hodgetts , Jason S. Newcom
IPC分类号: C07D405/14 , C07D401/04 , C07D403/04 , C07D413/14 , C07D417/14 , C07D401/14 , A61K31/517 , A61K45/06
CPC分类号: C07D405/14 , A61K31/517 , A61K45/06 , C07D401/04 , C07D401/14 , C07D403/04 , C07D413/14 , C07D417/14 , C07D487/04
摘要: Methods of treating disorders using compounds (I) that modulate stri-atal-enriched tyrosine phosphatase (STEP) are described herein. Exemplary disorders include schizophrenia and cognitive deficit. Formula (I).
摘要翻译: 本文描述了使用调节富含丝氨酸的酪氨酸磷酸酶(STEP)的化合物(I)治疗病症的方法。 示例性疾病包括精神分裂症和认知缺陷。 式(I)。
-
公开(公告)号:US20130053341A1
公开(公告)日:2013-02-28
申请号:US13520018
申请日:2010-12-30
申请人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahashi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimizu , Kevin J. Hodgetts , Jason S. Newcom
发明人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahashi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimizu , Kevin J. Hodgetts , Jason S. Newcom
IPC分类号: A61K31/517 , C07D413/14 , A61K31/5377 , A61K31/538 , C07D417/14 , A61K31/541 , A61K31/695 , A61P25/00 , A61P25/18 , A61P25/28 , A61K31/496 , A61K31/5513 , A61K31/519 , A61K31/554 , A61K31/5415 , C07D401/04
CPC分类号: C07D401/04 , A61K31/517 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D495/04
摘要: Methods of treating disorders using compounds that modulate striatal-enriched tyrosine phosphatase (STEP) are de-scribed herein. Exemplary disorders include schizophrenia and cognitive deficit.
摘要翻译: 本文描述了使用调节纹状体富含酪氨酸磷酸酶(STEP)的化合物治疗病症的方法。 示例性疾病包括精神分裂症和认知缺陷。
-
公开(公告)号:US20150307477A1
公开(公告)日:2015-10-29
申请号:US14692434
申请日:2015-04-21
申请人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahashi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimizu , Kevin J. Hodgetts , Jason S. Newcom
发明人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahashi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimizu , Kevin J. Hodgetts , Jason S. Newcom
IPC分类号: C07D401/14 , A61K31/517 , A61K45/06 , C07D401/04
CPC分类号: C07D401/04 , A61K31/517 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D495/04
摘要: Methods of treating disorders using compounds that modulate striatal-enriched tyrosine phosphatase (STEP) are described herein. Exemplary disorders include schizophrenia and cognitive deficit.
摘要翻译: 本文描述了使用调节纹状体富含酪氨酸磷酸酶的化合物(STEP)治疗病症的方法。 示例性疾病包括精神分裂症和认知缺陷。
-
公开(公告)号:US09073890B2
公开(公告)日:2015-07-07
申请号:US13520018
申请日:2010-12-30
申请人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahashi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimizu , Kevin J. Hodgetts , Jason S. Newcom
发明人: Masaki Suzuki , Kazumi Kondo , Muneaki Kurimura , Krishna Reddy Valluru , Akira Takahashi , Takeshi Kuroda , Haruka Takahashi , Tae Fukushima , Shin Miyamura , Indranath Ghosh , Abhishek Dogra , Geraldine Harriman , Amy Elder , Satoshi Shimizu , Kevin J. Hodgetts , Jason S. Newcom
IPC分类号: A01N43/90 , A61K31/519 , A01N43/54 , A61K31/517 , C07D491/00 , C07D495/00 , C07D401/00 , C07D403/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D495/04
CPC分类号: C07D401/04 , A61K31/517 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D495/04
摘要: Compounds, pharmaceutical compositions containing the compounds, and methods of using the compounds to treat a disorder, e.g., schizophrenia and cognitive deficit, in a subject are described herein. The compounds disclosed herein include quinoline and quinazoline-containing compounds that modulate striatal-enriched tyrosine phosphatase (STEP) activity.
摘要翻译: 本文描述了化合物,含有化合物的药物组合物,以及使用该化合物治疗受试者中的精神分裂症和认知缺陷症的方法。 本文公开的化合物包括调节富含纹状体的酪氨酸磷酸酶(STEP)活性的喹啉和喹唑啉化合物。
-
-
-